Skip to main content

Cyclobenzaprine Hydrochloride

NDC 0093-1921 · Teva Pharmaceuticals USA, Inc.

Generic nameCyclobenzaprine Hydrochloride
Dosage formCAPSULE, EXTENDED RELEASE
RouteORAL
Active ingredient(s)CYCLOBENZAPRINE HYDROCHLORIDE
Strength30 mg/1
Pharmacologic classCentrally-mediated Muscle Relaxation [PE], Muscle Relaxant [EPC]
Marketing categoryNDA AUTHORIZED GENERIC

Packages

0093-1921-06 — 60 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (0093-1921-06)

Related Codes

Same active ingredient

FDA lists these products with the same active ingredient.

0093-1920 — Cyclobenzaprine Hydrochloride, 0093-3420 — Cyclobenzaprine Hydrochloride, 0093-3421 — Cyclobenzaprine Hydrochloride, 0093-3422 — Cyclobenzaprine Hydrochloride, 0115-1436 — Cyclobenzaprine Hydrochloride, 0115-1437 — Cyclobenzaprine Hydrochloride, 0615-8084 — Cyclobenzaprine, 0615-8508 — Cyclobenzaprine hydrochloride, 0904-7400 — Cyclobenzaprine Hydrochloride, 0904-7401 — Cyclobenzaprine Hydrochloride, 10702-006 — Cyclobenzaprine Hydrochloride, 10702-007 — Cyclobenzaprine Hydrochloride, 16571-782 — Cyclobenzaprine Hydrochloride, 16571-783 — Cyclobenzaprine Hydrochloride, 24979-035 — Cyclobenzaprine Hydrochloride, 24979-036 — Cyclobenzaprine Hydrochloride, 29300-413 — Cyclobenzaprine hydrochloride, 29300-414 — Cyclobenzaprine hydrochloride, 29300-415 — Cyclobenzaprine hydrochloride, 33342-272 — Cyclobenzaprine Hydrochloride, +210 more

From the FDA National Drug Code Directory, retrieved August 24, 2026. Product listings are submitted by labelers; FDA does not verify them.